BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines collaboration & Other Revenue ($M) ($M)
Form 10-Q / 10-K Consolidated Statements of Operations (XBRL)
Latest, FY2025
61
Period ended Dec 31, 2025
Change on a year earlier
+98.7%
30.7 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Collaboration & Other Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61 | +98.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 30.7 | -88.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 269 | +66.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 161 | -70.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 542 | – | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 0 | -100.0% | Form 10-K (filed 2023-02-27) ↗ |
| FY2018 | Dec 31, 2018 | 67.3 | -68.6% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 214 | +19,354.5% | Form 10-K (filed 2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | 1.10 | – | Form 10-K (filed 2019-02-28) ↗ |
Breakdown
What makes up collaboration & other revenue ($m)
- Collaboration & Other Revenue — United States ($M)39.1 · FY2025
- Collaboration & Other Revenue — China ($M)20.2 · FY2025
- Collaboration & Other Revenue — Europe ($M)1.70 · FY2025
- Collaboration & Other Revenue — Rest of World ($M)0 · FY2025
- Collaboration R&D Service Revenue ($M, FY16–FY22)46.8 · FY2022
- Collaboration R&D Cost Reimbursement Revenue ($M, FY16–FY21)0 · FY2021
- Collaboration Right-to-Access IP Revenue ($M, FY19–FY22)105 · FY2022
- Other Collaboration Revenue ($M, FY17–FY22)9.50 · FY2022
Cite this data
StockData. (2026). BeOne Medicines Collaboration & Other Revenue ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev_collab_total
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.